|
|
|
|
|
|
|
03.11.25 - 14:03
|
Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences (GlobeNewswire EN)
|
|
|
MORRISVILLE, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases, announced today that members of the company's executive leadership team will be providing updates on the company's business during fireside chats at the following two investor conferences in November:...
|
|
|
|
|
03.11.25 - 12:33
|
Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire EN)
|
|
|
MORRISVILLE, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, today announced its financial results for the third quarter ended September 30, 2025. The company will also host a webcast at 8:30 a.m. Eastern Time on November 3, 2025, to review financial performance and provide a corporate update....
|
|
|
|
|
|
|
|
|
27.10.25 - 13:33
|
Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025 (GlobeNewswire EN)
|
|
|
MORRISVILLE, N.C., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its third quarter 2025 financial results on Monday, November 3, 2025. The company will host a webcast at 8:30 a.m. Eastern Time to discuss its financial results and provide a corporate update....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
07.10.25 - 12:33
|
Liquidia Corporation to Host R&D Day in New York City on October 28, 2025 (GlobeNewswire EN)
|
|
|
MORRISVILLE, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that it will host a Research & Development Day (R&D Day) on Tuesday, October 28, 2025, in New York City which will be webcast from 2:00 p.m. to 4:30 p.m. Eastern Standard Time. ...
|
|
|
29.09.25 - 14:33
|
Liquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual Meeting (GlobeNewswire EN)
|
|
|
MORRISVILLE, N.C., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, announced today the company will present two oral presentations at the CHEST 2025 annual meeting on October 19-22, 2025, in Chicago. The company's two presentations will focus on new data from its ASCENT trial pertaining to both the safety and exploratory efficacy of LIQ861 DPI treprostinil in PH-ILD patients through Week 16, and observed changes in the cardiac effort of PH-ILD patients.Oral Presentations include:Rapid Fire Oral Presentation, Tuesday, October 21, 2025, 10:20 a.m. – 10:24 a.m. CTTitle: Changes in Cardiac Effort in Pulmonary Hypertension-Interstitial Lung Disease: Insights from ASCENTPresenter: Dr. Dan Lachant - University of Rochester Medical CenterSession: On the Hunt for New Approaches to Diagnose and Monitor PHLate-Breaking Rapid Fire Oral Presentation, Tuesday, October 21, 2025, 1:52...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
